CLINICAL STUDIES
Maternally inherited cardiomyopathy: clinical and molecular characterization of a large kindred harboring the A4300G point mutation in mitochondrial deoxyribonucleic acid
Carlo Casali, MD, PhD*,
Giulia dAmati, MD, PhD ,
Paola Bernucci, MD, PhD ,
Luciano DeBiase, MD ,
Camillo Autore, MD ,
Filippo M. Santorelli, MD*,
Domenico Coviello, PhD|| and
Pietro Gallo, MD
* Istituto di Clinica delle Malattie Nervose e Mentali, Università di RomaLa Sapienza, Rome, Italy
Dipartimento di Medicina Sperimentale e Patologia, Università di RomaLa Sapienza, Rome, Italy
Istituto di Chirurgia del Cuore e dei Grossi VasiCardiologia 2, Università di RomaLa Sapienza, Rome, Italy
Dipartimento di Scienze Cardiovascolari e Respiratorie, Università di RomaLa Sapienza, Rome, Italy
|| Istituto di Biologia e Genetica, Università di Genova, Genoa, Italy
Reprint requests and correspondence: Carlo Casali, MD, PhD, Istituto di Clinica delle Malattie Nervose e Mentali, Università di RomaLa Sapienza, Viale dellUniversità 30, 00186 Rome, Italy Casali{at}uniroma1.it
OBJECTIVES
The purpose of this study was to describe the clinical and molecular features of a large family with maternally inherited cardiomyopathy (MICM).
BACKGROUND
Recently, several mitochondrial deoxyribonucleic acid (mtDNA) point mutations have been associated with MICM. However, the distinctive clinical and morphologic features of MICM are not fully appreciated. This is partially due to the small size of the reported pedigrees, often lacking detailed clinical and laboratory information.
METHODS
Clinical and genetic analysis of the family was carried out.
RESULTS
Echocardiography showed mostly symmetrical hypertrophic cardiomyopathy in 10 family members. The illness had an unfavorable course. Progressive heart failure occurred in three subjects, who eventually died; one individual underwent heart transplantation. Electrocardiographic or echocardiographic signs of cardiac hypertrophy in the absence of significant clinical complaints were observed in five subjects. Neurologic examination was normal. The mutation was detected in blood from all available subjects. Abundance of mutated molecules ranged between 13% and 100% of total mtDNA genomes. The severity of the disease could not be foreseen by the proportion of mutation in blood.
CONCLUSIONS
This report contributes a better description of the clinical aspects of MICM and provides important clues to distinguish it from hypertrophic cardiomyopathy. We suggest that mtDNA mutations, particularly in the transfer ribonucleic acid for isoleucin, should be systematically searched in patients with MICM. The identification of an underlying maternally inherited mitochondrial DNA defect in familial cases of cardiomyopathy may considerably influence the management and genetic counseling of affected patients.
|
Abbreviations and Acronyms
| | HCM | = hypertrophic cardiomyopathy | | MICM | = maternally inherited cardiomyopathy | | mtDNA | = mitochondrial deoxyribonucleic acid | | PCR | = polymerase chain reaction | | tRNAIIe | = transfer ribonucleic acid for isoleucin |
|
This article has been cited by other articles:

|
 |

|
 |
 
R. W. Taylor, C. Giordano, M. M. Davidson, G. d'Amati, H. Bain, C. M. Hayes, H. Leonard, M. J. Barron, C. Casali, F. M. Santorelli, et al.
A homoplasmic mitochondrial transfer Ribonucleic Acid mutation as a cause of maternally inherited hypertrophic cardiomyopathy
J. Am. Coll. Cardiol.,
May 21, 2003;
41(10):
1786 - 1796.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Marin-Garcia, M. J. Goldenthal, and J. J. Filiano
Cardiomyopathy Associated With Neurologic Disorders and Mitochondrial Phenotype
J Child Neurol,
October 1, 2002;
17(10):
759 - 765.
[Abstract]
[PDF]
|
 |
|
|